THYROID CANCER METASTATIC

This adverse event was reported 281 times

These drugs are most commonly taken by patients reporting THYROID CANCER METASTATIC:

# Drug Count
0 LEVOTHYROXINE SODIUM 39
1 SORAFENIB 24
2 ADALIMUMAB 14
3 ACETAMINOPHEN 11
4 DENOSUMAB 11
5 EXENATIDE 11
6 IBUPROFEN 11
7 ASPIRIN 10
8 ATORVASTATIN CALCIUM 10
9 DABRAFENIB 10
See all common drugs associated with THYROID CANCER METASTATIC